2nd Quarter - Report

1DAY SOONER ACTION PROJECT INC. for 1DAY SOONER ACTION PROJECT INC.

Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives

LobbyistCovered position, as disclosed
KATHRYN TAYLOR LIVELLI New —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES

Bills named: S. 2333 (119th)

Medical/Disease Research/Clinical Labs MED

S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives

LobbyistCovered position, as disclosed
KATHRYN TAYLOR LIVELLI New —

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 2333 (119th)

Defense DEF

FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and strengthen interagency relationships for national security and emerging pathogen / pandemic preparedness. To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines

LobbyistCovered position, as disclosed
KATHRYN TAYLOR LIVELLI New —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.